Immutep Accounts Payable vs Capital Stock Analysis

IMMP Stock

USD 2.12 0.06 2.75%

Immutep financial indicator trend analysis is infinitely more than just investigating Immutep Ltd ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immutep Ltd ADR is a good investment. Please check the relationship between Immutep Accounts Payable and its Capital Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Accounts Payable vs Capital Stock

Accounts Payable vs Capital Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immutep Ltd ADR Accounts Payable account and Capital Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between Immutep's Accounts Payable and Capital Stock is 0.61. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Immutep Ltd ADR, assuming nothing else is changed. The correlation between historical values of Immutep's Accounts Payable and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Immutep Ltd ADR are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Accounts Payable i.e., Immutep's Accounts Payable and Capital Stock go up and down completely randomly.

Correlation Coefficient

0.61

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Immutep obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Immutep Ltd ADR are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Most indicators from Immutep's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immutep Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, Immutep's Selling General Administrative is relatively stable compared to the past year. As of 12/11/2024, Issuance Of Capital Stock is likely to grow to about 96.7 M, while Enterprise Value Over EBITDA is likely to drop (2.98).

	2021	2023	2024 (projected)
Reconciled Depreciation	3.0M	3.4M	2.3M
Net Interest Income	192.0K	1.1M	1.1M

Reconciled Depreciation Net Interest Income

Immutep fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Short Term Debt	Non Currrent Assets Other	Non Current Liabilities Total	Other Liab	Short Term Investments
Total Assets		0.3	0.94	1.0	0.53	-0.99	-0.82	0.57	0.99	0.04	0.99	0.83	0.95	0.17	0.34	-0.3	0.34	0.84	0.99	-0.02	-0.28	-0.31	0.4	-0.21	-0.21	0.56
Other Current Liab	0.3		0.29	0.3	0.04	-0.33	-0.36	0.24	0.31	0.01	0.28	0.56	0.45	-0.18	0.18	-0.01	0.11	0.37	0.3	-0.01	-0.16	-0.23	0.22	-0.12	-0.14	0.36
Total Current Liabilities	0.94	0.29		0.94	0.57	-0.93	-0.8	0.75	0.93	0.05	0.93	0.85	0.91	0.14	0.4	-0.24	0.42	0.84	0.94	-0.02	-0.26	-0.16	0.25	-0.19	-0.09	0.54
Total Stockholder Equity	1.0	0.3	0.94		0.56	-0.99	-0.79	0.57	1.0	0.0	1.0	0.81	0.94	0.18	0.33	-0.29	0.28	0.86	1.0	-0.07	-0.33	-0.27	0.44	-0.27	-0.26	0.58
Property Plant And Equipment Net	0.53	0.04	0.57	0.56		-0.57	-0.15	0.62	0.55	-0.56	0.61	0.22	0.44	0.29	0.13	-0.08	-0.24	0.85	0.59	-0.59	-0.57	0.55	0.44	-0.64	-0.51	0.53
Net Debt	-0.99	-0.33	-0.93	-0.99	-0.57		0.77	-0.62	-1.0	0.05	-0.99	-0.82	-0.95	-0.15	-0.36	0.28	-0.25	-0.88	-0.99	0.13	0.38	0.26	-0.49	0.31	0.29	-0.61
Retained Earnings	-0.82	-0.36	-0.8	-0.79	-0.15	0.77		-0.46	-0.8	-0.47	-0.75	-0.88	-0.85	0.02	-0.42	0.37	-0.74	-0.51	-0.77	-0.42	-0.23	0.6	-0.07	-0.3	-0.16	-0.33
Accounts Payable	0.57	0.24	0.75	0.57	0.62	-0.62	-0.46		0.58	-0.16	0.58	0.57	0.55	0.12	0.33	-0.02	0.29	0.74	0.59	-0.23	-0.31	0.17	0.21	-0.29	-0.13	0.46
Cash	0.99	0.31	0.93	1.0	0.55	-1.0	-0.8	0.58		-0.02	0.99	0.83	0.96	0.16	0.34	-0.3	0.29	0.86	1.0	-0.09	-0.33	-0.3	0.46	-0.26	-0.25	0.59
Non Current Assets Total	0.04	0.01	0.05	0.0	-0.56	0.05	-0.47	-0.16	-0.02		-0.09	0.18	0.04	-0.14	0.06	-0.37	0.63	-0.35	-0.07	0.99	0.58	-0.51	-0.59	0.66	0.52	-0.46
Cash And Short Term Investments	0.99	0.28	0.93	1.0	0.61	-0.99	-0.75	0.58	0.99	-0.09		0.78	0.93	0.21	0.31	-0.26	0.24	0.88	1.0	-0.15	-0.36	-0.23	0.48	-0.31	-0.28	0.61
Net Receivables	0.83	0.56	0.85	0.81	0.22	-0.82	-0.88	0.57	0.83	0.18	0.78		0.92	-0.19	0.57	-0.19	0.58	0.62	0.81	0.12	-0.02	-0.53	0.24	0.08	0.08	0.55
Common Stock Shares Outstanding	0.95	0.45	0.91	0.94	0.44	-0.95	-0.85	0.55	0.96	0.04	0.93	0.92		0.01	0.44	-0.28	0.39	0.79	0.94	-0.02	-0.21	-0.39	0.38	-0.14	-0.17	0.65
Inventory	0.17	-0.18	0.14	0.18	0.29	-0.15	0.02	0.12	0.16	-0.14	0.21	-0.19	0.01		-0.82	-0.45	-0.08	0.3	0.19	-0.14	-0.07	0.13	-0.03	-0.12	-0.15	-0.24
Other Current Assets	0.34	0.18	0.4	0.33	0.13	-0.36	-0.42	0.33	0.34	0.06	0.31	0.57	0.44	-0.82		0.35	0.29	0.2	0.33	0.03	-0.06	-0.15	0.22	0.0	0.07	0.51
Other Stockholder Equity	-0.3	-0.01	-0.24	-0.29	-0.08	0.28	0.37	-0.02	-0.3	-0.37	-0.26	-0.19	-0.28	-0.45	0.35		-0.22	-0.22	-0.25	-0.35	-0.07	0.24	0.23	-0.14	-0.12	0.36
Total Liab	0.34	0.11	0.42	0.28	-0.24	-0.25	-0.74	0.29	0.29	0.63	0.24	0.58	0.39	-0.08	0.29	-0.22		-0.02	0.26	0.6	0.71	-0.6	-0.46	0.78	0.7	-0.04
Property Plant And Equipment Gross	0.84	0.37	0.84	0.86	0.85	-0.88	-0.51	0.74	0.86	-0.35	0.88	0.62	0.79	0.3	0.2	-0.22	-0.02		0.88	-0.41	-0.57	0.14	0.53	-0.56	-0.49	0.65
Total Current Assets	0.99	0.3	0.94	1.0	0.59	-0.99	-0.77	0.59	1.0	-0.07	1.0	0.81	0.94	0.19	0.33	-0.25	0.26	0.88		-0.14	-0.34	-0.24	0.47	-0.29	-0.27	0.61
Intangible Assets	-0.02	-0.01	-0.02	-0.07	-0.59	0.13	-0.42	-0.23	-0.09	0.99	-0.15	0.12	-0.02	-0.14	0.03	-0.35	0.6	-0.41	-0.14		0.62	-0.48	-0.63	0.69	0.54	-0.5
Short Long Term Debt Total	-0.28	-0.16	-0.26	-0.33	-0.57	0.38	-0.23	-0.31	-0.33	0.58	-0.36	-0.02	-0.21	-0.07	-0.06	-0.07	0.71	-0.57	-0.34	0.62		-0.5	-0.61	0.97	0.69	-0.36
Short Term Debt	-0.31	-0.23	-0.16	-0.27	0.55	0.26	0.6	0.17	-0.3	-0.51	-0.23	-0.53	-0.39	0.13	-0.15	0.24	-0.6	0.14	-0.24	-0.48	-0.5		-0.01	-0.59	-0.36	0.03
Non Currrent Assets Other	0.4	0.22	0.25	0.44	0.44	-0.49	-0.07	0.21	0.46	-0.59	0.48	0.24	0.38	-0.03	0.22	0.23	-0.46	0.53	0.47	-0.63	-0.61	-0.01		-0.67	-0.75	0.55
Non Current Liabilities Total	-0.21	-0.12	-0.19	-0.27	-0.64	0.31	-0.3	-0.29	-0.26	0.66	-0.31	0.08	-0.14	-0.12	0.0	-0.14	0.78	-0.56	-0.29	0.69	0.97	-0.59	-0.67		0.82	-0.41
Other Liab	-0.21	-0.14	-0.09	-0.26	-0.51	0.29	-0.16	-0.13	-0.25	0.52	-0.28	0.08	-0.17	-0.15	0.07	-0.12	0.7	-0.49	-0.27	0.54	0.69	-0.36	-0.75	0.82		-0.48
Short Term Investments	0.56	0.36	0.54	0.58	0.53	-0.61	-0.33	0.46	0.59	-0.46	0.61	0.55	0.65	-0.24	0.51	0.36	-0.04	0.65	0.61	-0.5	-0.36	0.03	0.55	-0.41	-0.48

Click cells to compare fundamentals

Immutep Account Relationship Matchups

Immutep fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	46.6M	82.0M	102.2M	147.4M	201.6M	211.7M
Other Current Liab	1.6M	3.1M	35.6M	4.1M	6.5M	4.1M
Total Current Liabilities	3.4M	5.3M	6.4M	9.8M	10.5M	11.0M
Total Stockholder Equity	33.3M	73.3M	94.1M	136.5M	189.5M	199.0M
Property Plant And Equipment Net	250.6K	309.7K	308.1K	468.5K	679.7K	713.7K
Net Debt	(17.3M)	(57.3M)	(78.3M)	(122.2M)	(160.2M)	(152.2M)
Retained Earnings	(275.7M)	(274.6M)	(302.3M)	(339.9M)	(382.6M)	(363.5M)
Accounts Payable	1.6M	1.8M	2.9M	5.4M	3.8M	2.3M
Cash	26.3M	60.1M	80.0M	123.4M	161.8M	169.9M
Non Current Assets Total	15.4M	13.6M	11.4M	12.5M	10.2M	11.0M
Cash And Short Term Investments	26.3M	60.1M	80.0M	123.4M	181.9M	191.0M
Net Receivables	3.4M	6.1M	8.4M	8.0M	7.6M	7.9M
Common Stock Shares Outstanding	407.3M	604.3M	862.3M	900.6M	1.2B	1.3B
Liabilities And Stockholders Equity	46.6M	82.0M	102.2M	147.4M	201.6M	211.7M
Other Current Assets	1.4M	7.8M	2.4M	3.6M	1.9M	1.7M
Other Stockholder Equity	33.3M	73.3M	38.7M	39.8M	1.0	0.95
Total Liab	13.3M	8.8M	8.1M	11.0M	12.1M	7.8M
Property Plant And Equipment Gross	250.6K	309.7K	941.1K	1.1M	1.3M	1.3M
Total Current Assets	31.2M	68.4M	90.8M	135.0M	191.4M	200.9M
Accumulated Other Comprehensive Income	66.0M	34.5M	29.0M	30.1M	30.1M	29.2M
Intangible Assets	15.1M	12.7M	10.4M	9.4M	8.1M	10.1M
Short Long Term Debt Total	9.1M	2.8M	1.7M	1.2M	1.6M	1.5M
Short Term Debt	129.4K	416.4K	173.4K	185.2K	233.6K	239.1K
Non Currrent Assets Other	(15.4M)	454.2K	495.7K	2.5M	1.3M	1.4M
Non Current Liabilities Total	9.9M	3.4M	1.7M	1.2M	1.6M	1.5M
Other Liab	1.0M	811.9K	117.3K	164.4K	189.1K	179.6K
Common Stock	243.0M	313.4M	367.4M	446.3M	542.1M	272.8M
Property Plant Equipment	250.6K	309.7K	308.1K	468.5K	421.7K	227.9K
Common Stock Total Equity	213.2M	221.1M	233.3M	313.4M	360.4M	225.2M
Net Tangible Assets	18.1M	60.4M	83.5M	127.0M	146.0M	153.3M
Long Term Debt	8.8M	2.5M	2.1M	835.4K	751.9K	714.3K
Capital Lease Obligations	262.4K	288.3K	408.3K	392.8K	451.7K	474.3K
Net Invested Capital	42.1M	75.8M	138.9M	137.3M	157.9M	165.8M
Net Working Capital	27.8M	63.1M	122.7M	125.2M	144.0M	151.2M
Capital Stock	243.0M	313.4M	534.1M	446.3M	513.2M	386.7M

Pair Trading with Immutep

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.

Moving against Immutep Stock

0.71	GILD	Gilead Sciences	Pair Corr
0.65	BMY	Bristol Myers Squibb	Pair Corr
0.5	FLGC	Flora Growth Corp	Pair Corr
0.4	ESPR	Esperion Therapeutics	Pair Corr
0.4	DNA	Ginkgo Bioworks Holdings	Pair Corr

The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.

The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC